Zepp Health (NYSE:ZEPP) versus 111 (NASDAQ:YI) Financial Contrast

Zepp Health (NYSE:ZEPP – Get Free Report) and 111 (NASDAQ:YI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Institutional and Insider Ownership

52.6% of Zepp Health shares are owned by institutional investors. Comparatively, 21.3% of 111 shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by company insiders. Comparatively, 43.9% of 111 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for Zepp Health and 111, as reported by MarketBeat.

Zepp Health presently has a consensus price target of $56.28, suggesting a potential upside of 552.22%. Given Zepp Health’s stronger consensus rating and higher possible upside, equities analysts plainly believe Zepp Health is more favorable than 111.

Risk & Volatility

Zepp Health has a beta of 2, meaning that its share price is 100% more volatile than the S&P 500. Comparatively, 111 has a beta of 0.66, meaning that its share price is 34% less volatile than the S&P 500.

Earnings & Valuation

This table compares Zepp Health and 111″s gross revenue, earnings per share and valuation.

111 has higher revenue and earnings than Zepp Health. 111 is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Zepp Health and 111’s net margins, return on equity and return on assets.

About Zepp Health

(Get Free Report)

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

About 111

(Get Free Report)

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.